已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

National Comprehensive Cancer Network Guideline Recommendations of Cancer Drugs With Accelerated Approval

医学 指南 报销 抗癌药物 家庭医学 食品药品监督管理局 癌症 批准的药物 药品审批 药品 内科学 药理学 医疗保健 病理 经济增长 经济
作者
Edward R. Scheffer Cliff,Rachel S. Rome,Aaron S. Kesselheim,Benjamin N. Rome
出处
期刊:JAMA network open [American Medical Association]
卷期号:6 (11): e2343285-e2343285 被引量:6
标识
DOI:10.1001/jamanetworkopen.2023.43285
摘要

Importance Many cancer drugs are approved under the US Food and Drug Administration (FDA) accelerated approval pathway based on preliminary evidence. It is unclear how this limited evidence is integrated into the National Comprehensive Cancer Network (NCCN) guidelines, which are common references for clinicians and are used by public and private payers to determine reimbursement for oncology treatments. Objective To analyze the NCCN guidelines’ assessments for cancer drug indications that received FDA accelerated approval compared with cancer drug indications that received FDA regular approval. Design, Setting, and Participants This cross-sectional study analyzes FDA-approved indications for cancer drugs that were granted accelerated approval from program inception in 1992 to June 30, 2022. For each drug, the FDA-approved labeling was reviewed to identify all indications. All analyses were performed at the drug-indication level. Exposure The exposure was FDA regulatory status as of October 2022, including regular approval, accelerated approval, accelerated approval converted to regular approval, and withdrawn accelerated approval. Main Outcomes and Measures The level of evidence and consensus (category 1, 2A, 2B, and 3) and treatment preference (preferred, alternative preferred, other recommended, and useful in certain circumstances) ratings assigned by NCCN committees as of February 2023. Results A total of 315 oncology indications for 100 drugs were analyzed. These indications included 156 (50%) with regular approval, 60 (38%) with accelerated approval, 78 (49%) with accelerated approval that was converted to regular approval, and 21 (13%) with withdrawn accelerated approvals. Among all indications, 105 (33%) were rated by the NCCN as having category 1 evidence, 185 (59%) with category 2A, 6 (2%) with category 2B, and 2 (1%) with category 3 evidence. Compared with indications with regular approval, those with accelerated approval were less frequently assigned category 1 evidence (47% vs 3%; P < .001) and were less often listed as preferred treatment options (58% vs 40%; P = .008). Among the 21 withdrawn accelerated approval indications, 8 (38%) remained in the NCCN guidelines, with most having level 2A evidence ratings. Conclusions and Relevance This study found that cancer drug indications with accelerated approval were less likely to be assigned high-level evidence ratings and preferred status in the NCCN guidelines compared with indications with regular approval; most accelerated and regular approval drugs had low-quality evidence ratings but high levels of consensus among oncologists on NCCN committees. Greater clarity on the thresholds and definitions of evidence levels would make the NCCN guidelines more useful to clinicians, patients, and payers.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
全何荣发布了新的文献求助10
1秒前
1秒前
小二郎应助Ultraman45采纳,获得10
2秒前
充电宝应助zx采纳,获得10
2秒前
子宁发布了新的文献求助10
3秒前
赘婿应助Hu采纳,获得10
4秒前
大模型应助bu才采纳,获得50
5秒前
辛勤的乌发布了新的文献求助10
7秒前
7秒前
Liu完成签到,获得积分10
8秒前
圆圆完成签到 ,获得积分10
9秒前
小方发布了新的文献求助10
9秒前
9秒前
11秒前
学术渣发布了新的文献求助10
13秒前
15秒前
子阅完成签到 ,获得积分10
15秒前
共享精神应助科研通管家采纳,获得10
16秒前
小蘑菇应助科研通管家采纳,获得10
16秒前
在水一方应助科研通管家采纳,获得10
16秒前
Lucas应助科研通管家采纳,获得10
16秒前
爆米花应助科研通管家采纳,获得10
16秒前
Ava应助科研通管家采纳,获得10
16秒前
上官若男应助科研通管家采纳,获得10
16秒前
慕青应助科研通管家采纳,获得10
17秒前
17秒前
情怀应助科研通管家采纳,获得10
17秒前
17秒前
17秒前
热心市民小红花应助fishfun采纳,获得10
17秒前
Ultraman45发布了新的文献求助10
17秒前
19秒前
Jasper应助叶强采纳,获得10
20秒前
慕青应助光而不耀采纳,获得10
21秒前
二一完成签到 ,获得积分10
21秒前
英俊的铭应助小方采纳,获得10
21秒前
22秒前
22秒前
庄冬丽发布了新的文献求助10
23秒前
23秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 700
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3976455
求助须知:如何正确求助?哪些是违规求助? 3520548
关于积分的说明 11203728
捐赠科研通 3257156
什么是DOI,文献DOI怎么找? 1798618
邀请新用户注册赠送积分活动 877819
科研通“疑难数据库(出版商)”最低求助积分说明 806523